Two-year outcomes of electrosurgery and calcium-enriched mixture pulpotomy in primary teeth: a randomised clinical trial

Khorakian, Fatemeh; Mazhari, Fatemeh; Asgary, Saeed; Sahebnasagh, Marzieh; Kaseb, Abbas Alizadeh; Movahhed, Taraneh; Shirazi, Alireza Sarraf

doi:10.1007/s40368-013-0102-z

Cited by 18 publications

(15 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…168 Clinical success of 100% and radiographic success of 90% were reported with calcium-enriched mixture cement used as a pulpotomy agent in human primary molars after 24 months' follow up, with the success rates of electrosurgical pulpotomy being similar. 169 When used as a direct pulp-capping material in human primary molars, calcium-enriched mixture cement demonstrated no radiographic failures after 6 months' follow up, with clinical success rate of 94.8%. 170 Similar outcomes were achieved when calcium-enriched mixture cement and MTA were used as pulpotomy agents to induce apexogenesis of immature carious lesion pulp-exposed permanent molars (ages 6-10 years) after 12 months' follow up.…”

Section: Clinical Applications Of Calcium-enriched Mixture Cementmentioning

confidence: 86%

“…Calcium‐enriched mixture cement and nano‐hydroxyapatite were compared as direct pulp capping materials in sound human primary canines scheduled for orthodontic extraction, with calcium‐enriched mixture cement found to be superior to nano‐hydroxyapatite in terms of dentine bridge formation and pulp health 2 months after application . Clinical success of 100% and radiographic success of 90% were reported with calcium‐enriched mixture cement used as a pulpotomy agent in human primary molars after 24 months' follow up, with the success rates of electrosurgical pulpotomy being similar . When used as a direct pulp‐capping material in human primary molars, calcium‐enriched mixture cement demonstrated no radiographic failures after 6 months' follow up, with clinical success rate of 94.8% .…”

Section: Clinical Applications Of Calcium‐enriched Mixture Cementmentioning

confidence: 96%

See 1 more Smart Citation

Calcium silicate‐based cements: composition, properties, and clinical applications

Dawood

Parashos

Wong

et al. 2015

J of Invest & Clin Dent

184

163

View full text Add to dashboard Cite

Mineral trioxide aggregate (MTA) is a calcium silicate-based cement (CSC) commonly used in endodontic procedures involving pulpal regeneration and hard tissue repair, such as pulp capping, pulpotomy, apexogenesis, apexification, perforation repair, and root-end filling. Despite the superior laboratory and clinical performance of MTA in comparison with previous endodontic repair cements, such as Ca(OH) , MTA has poor handling properties and a long setting time. New CSC have been commercially launched and marketed to overcome the limitations of MTA. The aim of the present review was to explore the available literature on new CSC products, and to give evidence-based recommendations for the clinical use of these materials. Within the limitations of the available data in the literature regarding the properties and performance of the new CSC, the newer products could be promising alternatives to MTA; however, further research is required to support this assumption.

show abstract

Section: Clinical Applications Of Calcium-enriched Mixture Cementmentioning

confidence: 86%

Section: Clinical Applications Of Calcium‐enriched Mixture Cementmentioning

confidence: 96%

Calcium silicate‐based cements: composition, properties, and clinical applications

Dawood

Parashos

Wong

et al. 2015

J of Invest & Clin Dent

184

163

View full text Add to dashboard Cite

show abstract

“…However, others have reported that CEM cement was not significantly different in outcome compared to electrosurgery+zinc oxide eugenol (ZOE) (Khorakian et al . ).…”

Section: Vital Pulp Therapiesmentioning

confidence: 97%

Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview – part I: vital pulp therapy

2017

View full text Add to dashboard Cite

Mineral trioxide aggregate (MTA) is a bioactive endodontic cement (BEC) mainly comprised of calcium and silicate elements. The cement was introduced by Torabinejad in the 1990s and has been approved by the Food and Drug Administration to be used in the United States in 1997. A number of new BECs have also been introduced to the market, including BioAggregate, Biodentine, BioRoot RCS, calcium-enriched mixture cement, Endo-CPM, Endocem, EndoSequence, EndoBinder, EndoSeal MTA, iRoot, MicroMega MTA, MTA Bio, MTA Fillapex, MTA Plus, NeoMTA Plus, OrthoMTA, Quick-Set, RetroMTA, Tech Biosealer and TheraCal LC. It has been claimed that these materials have properties similar to those of MTA without its drawbacks. In this article, the chemical composition and the application of MTA and other BECs for vital pulp therapy (VPT), including indirect pulp cap, direct pulp cap, partial pulpotomy, pulpotomy and partial pulpectomy, have been reviewed and compared. Based on selected keywords, all papers regarding chemical composition and VPT applications of BECs had been reviewed. Most of the materials had calcium and silicate in their composition. Instead of referring to the cements based on their chemical compositions, we suggest the term 'bioactive endodontic cements (BECs)', which seems more appropriate for these materials because, in spite of differences in their chemical compositions, bioactivity is a common property for all of them. Numerous articles were found regarding use of BECs as VPT agents for indirect and direct pulp capping, partial pulpotomy and cervical pulpotomy. Most of these investigations used MTA for VPT. In most studies, newly introduced materials have been compared to MTA. Some of the BECs have shown promising results; however, the number of their studies compared to investigations on MTA is limited. Most studies had several methodological shortcomings. Future investigations with rigorous methods and materials are needed.

show abstract

“…Although primary tooth pulpotomy is a technique very studied for several years, it is still controversial and much discussed due to the lack of effective medications and the difficulty of an accurate diagnosis of the pulp conditions to achieve treatment success. Continuously, several pulpotomy capping materials have been researched through clinical and laboratorial studies aiming to know the action mechanism of the medications, their clinical indication, advantages, and disadvantages, but a consensus on the ideal pulpotomy technique has not yet been reached.…”

Section: Introductionmentioning

confidence: 99%

Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth

Fernandes

Neto

Marques

et al. 2014

Int J Paed Dentistry

View full text Add to dashboard Cite

show abstract

Two-year outcomes of electrosurgery and calcium-enriched mixture pulpotomy in primary teeth: a randomised clinical trial

Abstract: The results of this investigation show that the treatment success rate with CEM cement was similar to the electrosurgical pulpotomy.

Cited by 18 publications

References 18 publications

Calcium silicate‐based cements: composition, properties, and clinical applications

Calcium silicate‐based cements: composition, properties, and clinical applications

Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview – part I: vital pulp therapy

Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth

Contact Info

Product

Resources

About